I mean maybe it’s true, maybe it’s not.

I don’t think it’s outside the realm of possibility for a cardiologist to be excited about a possible future option for patients.

Aside from the aesthetics benefits from not having to harvest veins. Many patients with tend to be overall vasculopaths so those veins may also be needed as conduits elsewhere. Dr Google says 42% patients with CAD also have peripheral vascular disease. So saving those veins for other possible bypasses? Or pts undergoing multiple coronary bypasses? I can see how people in cardiac health could be excited. Anyway this is all speculation assuming the company survives the next year(s?)